SSTR-positive neuroendocrine tumors: peptide receptor radionuclide therapy

被引：0
|
作者：
不详
机构：
来源：
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY | 2023年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S66 / S69
页数：4
相关论文
共 50 条
  • [41] Neuroendocrine tumors: Peptide receptors radionuclide therapy (PRRT)
    Otte, Andreas
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2016, 19 (02): : 182 - 182
  • [42] Neuroendocrine tumors: Peptide receptors radionuclide therapy (PRRT)
    Papamichail, Dimitris G.
    Exadaktylou, Paraskevi E.
    Chatzipavlidou, Vasiliki D.
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2016, 19 (01): : 75 - 83
  • [43] Peptide Receptor Radionuclide Therapy (PRRT) as neoadjuvant therapy in neuroendocrine tumors - one center experience
    Opalinska, M.
    Sowa-Staszczak, A.
    Grochowska, A.
    Zwinczewska, H.
    Hubalewska-Dydejczyk, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S334 - S334
  • [44] SSTR-directed Peptide Receptor Radionuclide Therapy in recurrent Meningioma
    Hartrampf, P.
    Mueller, M.
    Serfling, S. E.
    Buck, A. K.
    Polat, B.
    Werner, R. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S672 - S672
  • [45] Initial experience with somatostatin receptor (SSTR) imaging and peptide receptor radionuclide therapy for patients with neuroendocrine differentiation (NED) of prostate cancer
    Assadi, M.
    Rekabpour, S.
    Ahmadzadehfar, H.
    Jafari, E.
    Amini, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S696 - S697
  • [46] The efficacy of the available peptide receptor radionuclide therapy for neuroendocrine tumors: a meta-analysis
    Dannoon, Shorouk F.
    Alenezi, Saud A.
    Elgazzar, Abdelhamid H.
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (12) : 1085 - 1093
  • [47] Lu-177-Based Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors
    Kim K.
    Kim S.-J.
    Nuclear Medicine and Molecular Imaging, 2018, 52 (3) : 208 - 215
  • [48] Peptide receptor radionuclide therapy in patients with pulmonary neuroendocrine tumors: our experience.
    Minutoli, F.
    Cardile, D.
    Cucinotta, M.
    Quartuccio, N.
    Gangemi, V.
    Sindoni, A.
    Baldari, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S531 - S531
  • [49] Retrospective study of peptide receptor radionuclide therapy for Japanese patients with advanced neuroendocrine tumors
    Kobayashi, Noritoshi
    Wild, Damian
    Kaul, Felix
    Shimamura, Takeshi
    Takano, Shoko
    Takeda, Yuma
    Okubo, Naoki
    Suzuki, Akihiro
    Tokuhisa, Motohiko
    Ichikawa, Yasushi
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2021, 28 (09) : 727 - 739
  • [50] Peptide receptor radionuclide therapy for advanced gastroenteropancreatic neuroendocrine tumors - from oncology perspective
    Kolasinska-Cwikla, Agnieszka
    Lowczak, Anna
    Maciejkiewicz, Katarzyna
    Cwikla, Jaroslaw B.
    NUCLEAR MEDICINE REVIEW, 2018, 21 (02) : 115 - 124
12345